4//SEC Filing
MERIDIAN VENTURE PARTNERS II LP 4
Accession 0001144204-19-039648
CIK 0001023024other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 6:07 PM ET
Size
14.8 KB
Accession
0001144204-19-039648
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2019-08-12$71.45/sh−21,016$1,501,593→ 2,309,683 total - Sale
Common Stock
2019-08-13$71.77/sh−20,821$1,494,323→ 2,288,862 total - Sale
Common Stock
2019-08-09$71.70/sh−19,860$1,423,962→ 2,330,699 total
Brown Robert E. JR
Director10% Owner
Transactions
- Sale
Common Stock
2019-08-09$71.70/sh−19,860$1,423,962→ 2,330,699 total - Sale
Common Stock
2019-08-13$71.77/sh−20,821$1,494,323→ 2,288,862 total - Sale
Common Stock
2019-08-12$71.45/sh−21,016$1,501,593→ 2,309,683 total
Meridian Venture Partners II, Co.
10% Owner
Transactions
- Sale
Common Stock
2019-08-12$71.45/sh−21,016$1,501,593→ 2,309,683 total - Sale
Common Stock
2019-08-13$71.77/sh−20,821$1,494,323→ 2,288,862 total - Sale
Common Stock
2019-08-09$71.70/sh−19,860$1,423,962→ 2,330,699 total
MERIDIAN VENTURE PARTNERS II LP
10% Owner
Transactions
- Sale
Common Stock
2019-08-09$71.70/sh−19,860$1,423,962→ 2,330,699 total - Sale
Common Stock
2019-08-12$71.45/sh−21,016$1,501,593→ 2,309,683 total - Sale
Common Stock
2019-08-13$71.77/sh−20,821$1,494,323→ 2,288,862 total
Footnotes (4)
- [F1]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $70.84 to $71.78 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
- [F2]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $70.25 to $72.65 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
- [F3]The price reported in Column 4 is a weighted average price, rounded to the nearest cent. The shares were sold pursuant to a Rule 10b5-1 diversification plan entered into by the Reporting Person on June 6, 2019. The shares were sold in multiple transactions at prices ranging from $71.15 to $73.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by the Reporting Person at each separate price on each date of sale.
- [F4]Meridian Venture Partners II, Co. (MVP Corp.) is the general partner of Meridian Venture Partners II GP, L.P. (GP), the general partner of Meridian Venture Partners II, L.P. (MVP II). Robert E. Brown, Jr., a director of the issuer, is the President, sole stockholder and sole director of MVP Corp., as well as a limited partner of GP and one of two principals of MVP II.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeother
Related Parties
1- filerCIK 0001109507
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 6:07 PM ET
- Size
- 14.8 KB